SCARA5 and cancer: FTL gathered in cancer lesions to promote proliferation is potentially taken up from plasma via specific receptors, such as scavenger receptor class A member-5 (SCARA5) from the release of TAMs, particularly in response to pro-inflammatory cytokines [140,144].